Research Grade Retatrutide
- Cat. No.：RB9TSW328046
- Price：Negotiable
- Clicks：199
Product Detail
Product Parameters
| Form | Liquid |
|---|---|
| Isotype | Biosynthetic peptide. |
| Purity | >95% as determined by HPLC. |
| Purification | Purified by HPLC. |
| Concentration | 1 mg/ml |
| Endotoxin Level | Please contact with the lab for this information. |
| Applications | ELISA, Functional assay, Research in vivo |
| Species Reactivity | Human |
| Target | GLP-1 receptor, Glucagon-like peptide 1 receptor, GLP1R, GLP-1-R, GLP-1R, Gastric inhibitory polypeptide receptor, GIPR, GIP-R, Glucose-dependent insulinotropic polypeptide receptor, GCGR, Glucagon re |
| Storage Buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Accession Number | P43220 & P48546 & P47871 |
| Background | Retatrutide is an investigational triple-hormone receptor agonist developed by Eli Lilly and Company, targeting the receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. This unique mechanism aims to address metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH). |
| Alternative Names | LY3437943 |
| Species | Human |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Related Products: